Vlasak R, Sim F H
Department of Orthopedic Oncology, Mayo Clinic/Mayo Foundation Rochester, Minnesota 55905, USA.
Orthop Clin North Am. 1996 Jul;27(3):591-603.
Ewing's sarcoma is the second most common primary malignant bone tumor of children. Tremendous strides in the multidisciplinary treatment of Ewing's sarcoma have been made over the past 25 years. Aggressive chemotherapy has increased the 5-year survival rates from 10% to over 70%. The role of surgery for local control has gained importance. These advances in the diagnosis, staging, and treatment of Ewing's sarcoma are discussed in detail.
尤因肉瘤是儿童第二常见的原发性恶性骨肿瘤。在过去25年里，尤因肉瘤的多学科治疗取得了巨大进展。积极的化疗使5年生存率从10%提高到了70%以上。手术在局部控制方面的作用变得更加重要。本文将详细讨论尤因肉瘤在诊断、分期和治疗方面的这些进展。
